Cowen and Company’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Cowen and Company’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-132,716	Closed	-$1.36M	–	762
2023 Q2	$1.36M	Buy	132,716 +121,816	+1,118%	+$1.24M	0.11%	123
2023 Q1	$110K	Sell	10,900 -2,997	-22%	-$30.2K	0.01%	186
2022 Q4	$139K	Buy	+13,897	New	+$137K	0.01%	189

Cowen and Company's DALS Position: Q3 2023 in Review

Cowen and Company sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 132,716 shares — an estimated $1.36M sold.

Cowen and Company first reported a position in DALS in Q4 2022 and held it in 3 quarters. The position peaked at $1.36M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

Cowen and Company reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Cowen and Company sold 132,716 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $1.36M.
Cowen and Company first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q4 2022 and held it in 3 quarters.
Cowen and Company's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $1.36M in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Cowen and Company's 13F filing for Q3 2023, filed 9 Nov 2023.